Dimensional Fund Advisors
ETTX

Dimensional Fund Advisors’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Dimensional Fund Advisors’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70,688
Closed -$156K – 3588
2022
Q2 		$156K Sell
70,688
-9,347
-12% -$18.7K ﹤0.01% 3277
2022
Q1 		$150K Sell
80,035
-1,869
-2% -$3.4K ﹤0.01% 3346
2021
Q4 		$179K Buy
81,904
+55,834
+214% +$151K ﹤0.01% 3361
2021
Q3 		$87K Buy
+26,070
New +$70.7K ﹤0.01% 3441

Dimensional Fund Advisors's ETTX Position: Q3 2022 in Review

Dimensional Fund Advisors sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 70,688 shares — an estimated $156K sold.

Dimensional Fund Advisors first reported a position in ETTX in Q3 2021 and held it in 4 quarters. The position peaked at $179K in Q4 2021. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

  • Dimensional Fund Advisors reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 70,688 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $156K.
  • Dimensional Fund Advisors first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2021 and held it in 4 quarters.
  • Dimensional Fund Advisors's Entasis Therapeutics Holdings Inc. position peaked at $179K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.